Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
IPO Window: KPMG U.S. National Leader for Capital Markets Readiness Shari Mager, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Preventing Cyber Attacks: GeoComply CEO & Founder Anna Sainsbury, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
On-Demand Payment: DailyPay Chief Financial Officer Ken Brause, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
American Renewable Energy: Controlled Thermal Resources CEO Rod Colwell, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
AI-Powered Analytics: ThoughtSpot Chief Financial Officer Mohit Daswani, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
IPOs & SPACs: Stifel Managing Director Craig DeDomenico, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Cyber Threat Mitigation: Semperis Chief Financial Officer Jeff Bray, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
